Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video)
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Background

EUS-guided biliary drainage (EUS-BD) was introduced as an effective alternative to percutaneous transhepatic biliary drainage after failed ERCP. However, EUS-BD is technically challenging. The intraductal manipulation of the guidewire seems to be the most difficult stage of the procedure. Therefore, technical advances in guidewire manipulation may be required for EUS-BD.

Objective

To evaluate our treatment algorithm for guidewire manipulation protocol for EUS-BD after failed ERCP.

Design

Prospective, observational cohort study.

Setting

A tertiary-care academic center.

Patients

Forty-five consecutive patients undergoing EUS-BD failed ERCP.

Interventions

Enhanced guidewire manipulation protocol (with a plane parallel to the long axis of the bile duct with an EUS needle tip or a new 0.025-inch guidewire in an extrahepatic approach and intrahepatic bile duct puncture of segment 2 and 4F cannula with guidewire probing in the intrahepatic approach) for rendezvous and antegrade therapy, EUS-BD with transluminal stenting for duodenal invasion, and crossover to another technique if each technique failed.

Main Outcome Measurements

Technical and functional success rates and adverse event rate of the current treatment algorithm for EUS-BD.

Results

The overall technical and functional success rates of EUS-BD in this study were 91 % (intention to treat, n = 41/45) and 95 % (per protocol, n = 39/41), respectively. Specifically, rendezvous (n = 20) and antegrade therapy (n = 14) were initially feasible in 34 of 45 patients (76 % ). With our protocol, 25 of 45 patients (56 % ) were eventually treated with rendezvous and antegrade therapy as a first-line or crossover treatment. EUS-guided biliary drainage with transluminal stenting in patients with duodenal invasion or failed antegrade therapy was feasible in the remaining 20 patients (44 % ). The overall adverse event rate of EUS-BD was 11 % .

Limitations

Single-operator, nonrandomized study.

Conclusions

In this prospective study, our treatment algorithm with an enhanced guidewire manipulation protocol appeared to be technically feasible and effective. Given the favorable success rate and acceptable adverse event rate, this may be considered the standard treatment algorithm for future randomized trials of EUS-BD and percutaneous transhepatic biliary drainage.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700